Insulin glargine and Panitumumab Intravenous
Determining the interaction of Insulin glargine and Panitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
Generic Name: panitumumab
Brand name: Vectibix
Synonyms: Panitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine-Panixine
- Insulin glargine-Panixine DisperDose
- Insulin glargine-Panlor
- Insulin glargine-Panlor Tablet
- Insulin glargine-Panlor Tablets
- Insulin glargine-Panlor-DC
- Panitumumab Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Panitumumab Intravenous-Insulin Glargine (U-100) Vials
- Panitumumab Intravenous-Insulin Glargine (U-300) Pens
- Panitumumab Intravenous-Insulin glargine and lixisenatide
- Panitumumab Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Panitumumab Intravenous-Insulin glargine, recombinant Subcutaneous